Company profile
Ticker
KV+A
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
KV Pharmaceutical Co
SEC CIK
Corporate docs
IRS number
430618919
Latest filings (excl ownership)
15-12B
Securities registration termination
9 Apr 14
8-K
Departure of Directors or Certain Officers
6 Nov 13
8-K
KV Pharmaceutical Company Appoints Two New Board Members
18 Oct 13
15-12G
Securities registration termination
15 Oct 13
8-K
KV Pharmaceutical Company Appoints Former Wyeth Pharmaceuticals President, Joe Mahady to Chairman of the Board
4 Oct 13
D
$260.88M in equity, sold $260.88M, 28 investors
25 Sep 13
8-K
United States Bankruptcy Court Southern District of New York
23 Sep 13
8-K
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
23 Sep 13
8-K/A
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
23 Sep 13
8-K
United States Bankruptcy Court Southern District of New York
5 Sep 13
Latest ownership filings
11-K
Annual report of employee stock purchases
27 Sep 13
SC 13G
K-V Pharmaceutical Co
26 Sep 13
SC 13D/A
KV Pharmaceutical Co /De/
7 Aug 13
SC 13D
KV Pharmaceutical Co /De/
5 Aug 13
SC 13D
KV Pharmaceutical Co /De/
1 Aug 13
SC 13D
KV Pharmaceutical Co /De/
24 Jul 13
SC 13D
KV Pharmaceutical Co /De/
16 Jul 13
SC 13D
KV Pharmaceutical Co /De/
12 Jul 13
SC 13D/A
AmediusTec Ltd.
28 Sep 12
11-K
Annual report of employee stock purchases
27 Sep 12